DrugsControl Media Services
DrugsControl.org

News Detail

NIPER, Mohali gets patent for its invention for new anti-TB compound (11-10-2022)

New Delhi, 11 Oct 2022: The Indian Patent Office (IPO) has granted a patent application submitted by the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, for the rights of a compound as anti-tubercular agents and an improved process for its preparation......
View Details

Source : Pharmabiz
Indian Patent Office IPO NIPER anti-tubercular Novel 2-(2'-Aminophenyl) benzazoles tuberculosis human immunodeficiency virus HIV. DOTS MDR-TB XDR-TB benzoxazole benzthizoles Global TB Report 2021

Related News